Glynase XL (Glucotrol XL)10MG – 100 tablet


Each Glynase XL contains 10 mg Glipizide 100 tablets. Used as a common medication used to treat diabetes mellitus type 2 in adults

ATC Classification: A10BB07
Active Ingrediant: Glipizide
Generic Name: Glynase XL
Manufacturer: USV Ltd
Strength: 10MG
Dosage Type: Tablet XL
Packaging Type: Foil in Box
Contains: 100 Tab

Glipizide Information

What is this drug used for?

• It is used to lower blood sugar in patients with high blood sugar (diabetes).


Possible side effects

Glipizide may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

• Dizziness.
• Diarrhea.
• Feeling nervous and excitable.
• Gas.

Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

• Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
• Change in eyesight.
• Slurred speech.
• Tingling.
• Feeling very tired or weak.
• Low blood sugar can happen. The chance may be raised when this drug is used with other drugs for diabetes. Signs may be dizziness, headache, feeling sleepy or weak, shaking, fast heartbeat, confusion, hunger, or sweating. Call your doctor right away if you have any of these signs. Follow what you have been told to do for low blood sugar. This may include taking glucose tablets, liquid glucose, or some fruit juices.


Medication Safety Issues

Sound-alike/look-alike issues:

GlipiZIDE may be confused with glimepiride, glyBURIDE

Glucotrol may be confused with Glucophage, Glucotrol XL, glyBURIDE, GlycoTrol (dietary supplement)

High alert medication:

The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.


Storage and Stability

Extended release: Store at 68°F to 77°F (20°C to 25°C); excursions permitted between 59°F to 86°F (15°C to 30°C). Protect from moisture and humidity.

Immediate release: Store below 30°C (86°F).


Adverse Reactions

Frequency not always defined.

Cardiovascular: Syncope (<3%)

Central nervous system: Dizziness (2% to 7%), nervousness (4%), anxiety (<3%), depression (<3%), hypoesthesia (<3%), insomnia (<3%), pain (<3%), paresthesia (<3%), drowsiness (2%), headache (2%)

Dermatologic: Diaphoresis (<3%), pruritus (1% to <3%), eczema (1%), erythema (1%), maculopapular rash (1%), morbilliform rash (1%), skin rash (1%), urticaria (1%)

Endocrine & metabolic: Hypoglycemia (<3%), increased lactate dehydrogenase

Gastrointestinal: Diarrhea (1% to 5%), flatulence (3%), dyspepsia (<3%), vomiting (<3%), constipation (1% to <3%), nausea (1% to <3%), abdominal pain (1%)

Hepatic: Increased serum alkaline phosphatase, increased serum AST

Neuromuscular & skeletal: Tremor (4%), arthralgia (<3%), leg cramps (<3%), myalgia (<3%)

Ophthalmic: Blurred vision (<3%)

Renal: Increased blood urea nitrogen, increased serum creatinine

Respiratory: Rhinitis (<3%)

1%, postmarketing, and/or case reports: Agranulocytosis, anorexia, aplastic anemia, bloody stools, cardiac arrhythmia, chills, cholestatic jaundice, confusion, conjunctivitis, decreased libido, disulfiram-like reaction, dyspnea, dysuria, edema, eye pain, flushing, hemolytic anemia, hepatic injury, hypertension, hypertonia, hyponatremia, jaundice, leukopenia, migraine, pancytopenia, pharyngitis, porphyria, retinal hemorrhage, SIADH (syndrome of inappropriate antidiuretic hormone secretion), skin photosensitivity, thrombocytopenia, unsteady gait, vertigo

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


Dosage Type

Packaging Type




There are no reviews yet.

Be the first to review “Glynase XL (Glucotrol XL)10MG – 100 tablet”

Your email address will not be published. Required fields are marked *